Elicio Therapeutics (ELTX) EPS (Basic) (QoQ) (2020 - 2026)
Elicio Therapeutics (ELTX) EPS (Basic) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - |
| 10 | Elicio Therapeutics | 58.79 Mn | 35.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.70% |
| Mar 31, 2026 | -101.48% |
| Dec 31, 2025 | 45.53% |
| Sep 30, 2025 | -6.23% |
| Jun 30, 2025 | -23.55% |
| Mar 31, 2025 | 20.27% |
| Dec 31, 2024 | -38.75% |
| Sep 30, 2024 | 54.59% |
| Jun 30, 2024 | -61.49% |
| Mar 31, 2024 | 46.50% |
| Dec 31, 2023 | 17.91% |
| Sep 30, 2023 | 35.10% |
| Jun 30, 2023 | -34.06% |
| Mar 31, 2023 | -34.27% |
| Dec 31, 2022 | 40.66% |
| Sep 30, 2022 | -38.75% |
| Jun 30, 2022 | 50.48% |
| Mar 31, 2022 | -197.52% |
| Dec 31, 2021 | 136.84% |
| Sep 30, 2021 | 8.22% |